LIVN - LivaNova's Neuromodulation Products Could Imply Significant Undervaluation
Summary
- LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world.
- Considering the geographic diversification of the business model, LivaNova’s revenue model appears to be more solid than that of competitors that operate only in one market.
- Considering that LivaNova is already present in a number of countries, I would expect that other insurance companies or health systems in other countries will likely sign agreements with management.
For further details see:
LivaNova's Neuromodulation Products Could Imply Significant Undervaluation